We additionally aimed to corroborate the molecular model of B-Myb-mediated DREAM complex disruption through biostatistical analyses of previously validated data sets and gene expression studies of patient-derived HGSOC tumor samples. The gene discussed is MYBL2; the disease is neoplasm.